Data / Form D filings / Biomark Diagnostics Inc.
Biomark Diagnostics Inc.: Form D filing
Biomark Diagnostics Inc., a biotechnology company in Richmond, British Columbia, Canada, filed a Form D with the SEC in 2025. The latest, on April 14, 2025, reports $2.5 million sold of a $2.5 million offering to 10 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 130 - 3851 SHELL RD, Richmond, British Columbia, Canada, V6X 2
- Phone
- (604) 370-0779
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- British Columbia, Canada
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2064257
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 14, 2025 | New notice | $2,491,954 | $2,491,954 | 10 | Mar 26, 2025 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Brian Kai-Ming Cheng | Director | |
| Guoyu Kai-Ming Huang | Executive Officer | |
| Bramhanand Ramjiawan | Director | |
| Rashid Bux | Executive Officer, Director |
Every Form D from the week of Apr 14, 2025 · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Biomark Diagnostics Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.